Russian journal of anaesthesiology and reanimatology 2, 2019 Клинические рекомендации фар
partum hemorrhage management: an Italian multidisciplinary attended pro-
жүктеу/скачать 0,76 Mb. Pdf көрінісі
|
Anestesiolog 2019 02 005
Оқулық Клиникаға кіріспе, 32, 34 тарих, Skleroz 2012 Nv9 005, Otorino 2014 03 041, TA 2013 11 073, Nv 2017 08 085, 2 основных дока гинек, Печать контента170
partum hemorrhage management: an Italian multidisciplinary attended pro- tocol. Clin Ter . 2017;168(5):307-316. 98. Ahmadzia H, Phillips J, Katler Q, James A. Tranexamic Acid for Prevention and Treatment of Postpartum Hemorrhage: An Update on Management and Clinical Outcomes. Obstet Gynecol Surv . 2018;73(10):587-594. 99. Vogel J, Oladapo O, Dowswell T, Gülmezoglu A. Updated WHO recom- mendation on intravenous tranexamic acid for the treatment of post-par- tum haemorrhage. Lancet Glob Health . 2018;6(1):18-19. 100. Jadon A, Bagai R. Blood transfusion practices in obstetric anaesthesia. In- dian J Anaesth . 2014;58(5):629-636. 101. Meier J. Blood transfusion and coagulation management. Best Pract Res Clin Anaesthesiol . 2016;30(3):371-379. 102. Kaufman R, Djulbegovic B, Gernsheimer T, Kleinman S, et al. AABB. Plate- let transfusion: a clinical practice guideline from the AABB. Ann Intern Med . 2015;162(3):205-213. 103. Waters J. Role of the massive transfusion protocol in the management of haemorrhagic shock. Br J Anaesth . 2014;113(Suppl 2):3-8. 104. National Blood Authority. Patient blood management guidelines: module 5-ob- stetrics and maternity . Canberra ACT (Australia): National Blood Authority; 2015;129. 105. Prevention and Management of Postpartum Haemorrhage: Green-top Guide- line No. 52. BJOG . 2017;124(5):106-149. 106. Bar-Natan M, Hymes K. Management of Intraoperative Coagulopathy. Neu- rosurg Clin N Am. 2018;29(4):557-565. 107. Butwick A, Goodnough L. Transfusion and coagulation management in ma- jor obstetric hemorrhage. Curr Opin Anaesthesiol . 2015;28(3):275-284. 108. Kwon J, MacLaren R. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Fa- cilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study. Pharmacotherapy . 2016;36(10):1047- 1054. 109. Brekelmans M, Ginkel K, Daams J, Hutten B, et al. Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antag- onist associated bleeding: a systematic review and metaanalysis. J Thromb Thrombolysis . 2017;44(1):118-129. 110. Chai-Adisaksopha C, Hillis C, Siegal D, Movilla R, et al. Prothrombin com- plex concentrates versus fresh frozen plasma for warfarin reversal. A system- atic review and metaanalysis. Thromb Haemost . 2016;116(5):879-890. 111. Refaai M, Goldstein J, Lee M, Durn B, et al. Increased risk of volume overload with plasma compared with four-factor prothrombin com- plex concentrate for urgent vitamin K antagonist reversal. Transfusion . 2015;55(11):2722-2729. 112. Goldstein J, Refaai M, Milling TJr, Lewis B, et al. Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open- label, non-inferiority, randomised trial. Lancet . 2015;385(9982):2077-2087. Клинические рекомендации ФАР FAR Clinical Recommendations 26 АНЕСТЕЗИОЛОГИЯ И РЕАНИМАТОЛОГИЯ 2, 2019 113. Johansen M, Wikkelsø A, Lunde J, Wetterslev J, Afshari A. Prothrombin com- plex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients. жүктеу/скачать 0,76 Mb. Достарыңызбен бөлісу:
|